Human cellular protein gastrointestinal glutathione peroxidase as target for medical intervention against hepatitis c virus infections
CA 2443525 A1 · Owner: Obert, Sabine · Inventors: Obert, Sabine; Herget, Thomas; Cotten, Matthew
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the human cellular protein glutathione peroxidase-gastrointestinal as potential targets for medical intervention against Hepatitis C virus (HCV) infections. Furthermore the present invention , relates to a method for the detection of compounds useful for prophylaxis and/or treatment of Hepatitis C virus infections and a method for detecting Hepatitic C virus infections in an individual or in cells. Also mono- or polyclonal antibodies are disclosed effective for the treatment of HCV infections together with methods for treating Hepatitis C virus infections or for the regulation of Hepatitis C virus production wherein said antibodies may be used.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 15, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 15, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 15, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.